SONIDA SENIOR LIVING, INC. Overview
Industry: Medical Care Facilities
Sector: Healthcare
Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It also offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, it offers memory care services; and home care services through third-party providers. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Addison, Texas. Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, Read MoreMavefund brings filings, fundamentals, valuation, price history and news for SONIDA SENIOR LIVING, INC. into one research view. The sections below show what strengthens or weakens the research case.
Score
Reported Results
What the company reported, with filing details kept small.
Quarterly result summary
sndaq4-fy2025investordec SNDA NYSE Listed Investor Presentation Fourth Quarter and Full Year 2025 March 11, 2026 The Ashton at Anderson Forward-Looking Statements 2 Explanatory Note As further described in the Company’s Current Report on Form 8-K filed with t...
What changed
- Review the SEC source filing for the full reported results and management commentary.
Guidance / outlook
we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected.
Earnings material
Open filing
Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.
Prediction-grade evidence
Recent News
Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.
Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026 (CELC)
Headline from Seeking Alpha: Celcuity: 'Buy' REVTORPYK FDA Approval First And sNDA Label Expansion Q3 2026 (CELC).
PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use
Headline from Yahoo Finance: PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use.
FDA Accepts Shionogi’s sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria
Headline from Yahoo Finance: FDA Accepts Shionogi’s sNDA for Fetroja® (cefiderocol) for Use in Pediatric Patients with Serious Infections Caused by Susceptible Gram-negative Bacteria.
Following FDA sNDA Acceptance Is Sarepta Therapeutics (SRPT) Still Undervalued?
Headline from Yahoo Finance: Following FDA sNDA Acceptance Is Sarepta Therapeutics (SRPT) Still Undervalued?
The Bull Case For Sarepta Therapeutics (SRPT) Could Change Following FDA sNDA Acceptance On DMD Therapies
Headline from Yahoo Finance: The Bull Case For Sarepta Therapeutics (SRPT) Could Change Following FDA sNDA Acceptance On DMD Therapies.
Biotech Analysis Central Model 10+ Portfolio #1 Arrowhead Pharmaceuticals; Positive Ph 3 SHASTA Program SHTG Plozasiran, sNDA End Of 2026, New RNAi Dual Silencing ARO-DIMER-PA, And Catalysts (NASDAQ:ARWR)
Headline from Seeking Alpha: Biotech Analysis Central Model 10+ Portfolio #1 Arrowhead Pharmaceuticals; Positive Ph 3 SHASTA Program SHTG Plozasiran, sNDA End Of 2026, New RNAi Dual Silencing ARO-DIMER-PA, And Catalysts (NASDAQ:ARWR).
Earnings Per Share
Score 3.00/5
SONIDA SENIOR LIVING, INC. boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
In
Medical Care Facilities industry
, Universal Health Services Inc
, DaVita HealthCare Partners Inc
, CHEMED CORP
are companies with high ratings.
Return on Equity
Score 3.62/5
SONIDA SENIOR LIVING, INC. stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
0%
10%
20%
30%
40%
ROE
Company —
Sector Median —
Metric chart temporarily unavailable.
Net Margin
Score 2.16/5
SONIDA SENIOR LIVING, INC.
olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
0%
10%
20%
30%
40%
Net Margin
Company —
Sector Median —
Metric chart temporarily unavailable.
Leverage
Score 1.31/5
SONIDA SENIOR LIVING, INC.
registers a lower score in the category as a result of its elevated leverage ratio over the past six years compared to the sector median value. Conversely, other companies in the same sector, including
Zoetis Inc
IQVIA Holdings Inc
Agilent Technologies Inc
have achieved high scores.
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
0
1
2
3
4
Leverage
Company —
Sector Median —
Metric chart temporarily unavailable.
Financial Statements
Company-reported SEC EDGAR facts organized into the three core statements.
Verified SEC statements load when this section enters view.
Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.
Financial Ratio
Yearly
Quarterly
Financial
Profitability
Growth
Cash Flow
Financial Health
Efficiency Ratios